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Dear Editor,
We present the case of a 43-year-old female patient with
an anaplastic IgG kappa multiple myeloma (MM) con-
firmed by morphological and molecular genetic analyses
showing a tumourous bone marrow infiltration by highly
atypical plasma cells (Fig. 1a) with strong expression of the
plasma cell marker CD138 (Fig. 1b) and the kappa light
chain (Fig. 1c, d reveals negative staining for lambda light
chain) as well as a monoclonal rearrangement of the
immunoglobulin heavy chain (IgH; Fig. 1e). In her 4-year
treatment history, she underwent conventional chemothera-
pies as well as two autologous and one allogeneic
peripheral blood stem cell transplantation from a matched
related donor. Ten months after the latter, she presented
with tumourous lesions in the left acetabulum, soft tissue,
liver and dura mater coincidental with serum IgG kappa
increase (IgG 2,400 mg/dL, free kappa light chains
1,550 mg/L), suggesting extramedullary manifestations of
MM. After a third, salvage high-dose chemotherapy with
autologous stem cell support, the patient received haploi-
dentical blood stem cell transplantation [1] in partial
remission. However, due to an enlargement of the extra-
medullar infiltrates with increasing IgG values and a
antibiotic/antimycotic therapy comprising fluconazole
400 mg/day, posaconazole 400 mg/day, voriconazole
400 mg/day, anidulafungin 100 mg/day and caspofungin
50 mg/day without substantial serological/microbiological
hints at an infectious etiology, a renewed progression of
MM was suspected. In a dramatically worsened terminal
course with multiorgan failure and progressive cerebral
clouding, the patient died under the suspicion of a
progressive extramedullary relapsed anaplastic MM.
In autopsy, we found multiple nodular infiltrates in the
liver (Fig. 2a, arrows) with parenchymatous scars and
subacute infarctions (Fig. 2b) as well as a subtotal
infarction of the right kidney and acute haemorrhagic
infarctions of the lung and the cerebellum (Fig. 2d, arrow)
showing fresh haemorrhages and necrosis in the cerebellar
cortex (Fig. 2e). However, no residuals of the MM were
detectable in the organ infiltrates neither by immunohisto-
chemistry nor by molecular genetic analyses (Figs. 2c and f,
showing polyclonal amplificates for the IgH rearrange-
ment). By contrast, we could demonstrate an extensive
vascular permeation with apparent occlusion of small to
medium arteries by hyphae (Fig. 3) in all organs involved
with subsequent haemorrhagic infarctions and the morpho-
logical diagnosis of mucormycosis (Fig. 3, inset) was
confirmed by specific polymerase chain reaction amplifi-
cation detecting Rhizopus species.
Extramedullary manifestations of MM occur in approx-
imately 20% of patients and diffuse hepatic infiltration was
even described in up to 50% of advanced cases [3].
However, since the differential diagnosis of extramedullary
tumours in the refractory phase of MM includes other
malignancies (e.g. transition to lymphoproliferative disor-
ders [2]) as well as infectious diseases, a proper diagnos-
tical clarification of any recurrent extramedullary tumour in
MM by histological/molecular genetic analyses should be
performed to improve the management and prognosis of
such lesions.
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Fig. 2 Multiple nodular infil-
trates in the liver (a, arrows)
with parenchymatous scars and
subacute infarctions (b) as well
as a subtotal infarction of the
right kidney and acute haemor-
rhagic infarctions of the lung
and the cerebellum (d, arrow)
showing fresh haemorrhages
and necrosis in the cerebellar
cortex (e). c and f Polyclonal
amplificates for the IgH
rearrangement
Fig. 1 Tumourous bone mar-
row infiltration by highly atypi-
cal plasma cells (a) with strong
expression of the plasma cell
marker CD138 (b) and the kap-
pa light chain (c) as well as
negative staining for lambda
light chain (d) and a monoclonal
rearrangement of the immuno-
globulin heavy chain (e)
386 Ann Hematol (2009) 88:385–387
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Bethge WA, Faul C, Bornhauser M, Stuhler G, Beelen DW,
Lang P et al (2008) Haploidentical allogeneic hematopoietic cell
transplantation in adults using CD3/CD19 depletion and reduced
intensity conditioning: an update. Blood Cells Mol Diseases 40:13–
19 doi:10.1016/j.bcmd.2007.07.001
2. Miwa A (2007) How to diagnose a patient precisely as a myeloma
patient?—Lots of problems during diagnostic process. Nippon
Rinsho 65:2268–2279
3. Perez Gil MA, Ruiz Recuento J, Relanzon Molinero S,
Martinez Yunta JA (2006) Focal liver lesions in multiple myeloma:
echography, computed tomography, and magnetic resonance find-
ings. Radiologia 48:251–254
Fig. 3 Extensive vascular permeation with apparent occlusion of
small to medium arteries by hyphae in all organs involved with
subsequent haemorrhagic infarctions and the morphological diagnosis
of mucormycosis (inset)
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